Director/PDMR Shareholding

RNS Number : 9666F

Dechra Pharmaceuticals PLC

26 February 2018

 

26 February 2018

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 26 February 2018, Richard Cotton exercised a nil cost option over ordinary shares of 1p each in the Company. The option was granted to him on 7 March 2017 as part of the recruitment award referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2017.

The exercise of the option was subject to a performance review, as result of which the vesting percentage is 100%.

Name	Capacity	Number of share over which option exercised	Total beneficial shareholding following this announcement	Percentage of issued share capital
Richard Cotton	Director	21,033	42,351	0.041%

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Richard Cotton
2.	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Exercise of an option granted as part of a recruitment award to acquire 21,033 shares
c)	Price(s) and volumes(s)	Price(s) £Nil Cost	Volume(s) 21,033
d)	Aggregated information -   Aggregate volume -   Price	N/A
e)	Date of the transaction	2018.02.26
f)	Place of the transaction	Outside a trading venue

For further information, please contact:

Melanie Hall, Company Secretary                         

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

DSHFKADQPBKDFBB